Cue Biopharma, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Cue Biopharma, Inc. (CUE) had Common Stock, Capital Shares Reserved for Future Issuance of 5.62 million shares as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-16
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 5.62M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 365.11K shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 3.31M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 566.25K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 5.62M shares 10-K · filed 2026-03-16 |
| 2024-12-31 | 365.11K shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 3.31M shares 10-K · filed 2024-03-28 |
| 2022-12-31 | 566.25K shares 10-K · filed 2023-03-21 |
| 2021-12-31 | 577.39K shares 10-K · filed 2022-03-16 |
| 2020-12-31 | 755.73K shares 10-K · filed 2021-03-09 |
| 2019-12-31 | 465.11K shares 10-K · filed 2020-03-12 |
| 2018-12-31 | 648.45K shares 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |